Merck & Co., Inc. - 19 Dec 2024 Form 3 Insider Report for Personalis, Inc. (PSNL)

Reporting relationship: 10%+ Owner
Issuer ticker: PSNL
Reported as of: 19 Dec 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 23 Dec 2024, 06:00:18 UTC
Prior SEC filing: 11 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Kelly Grez, Corporate Secretary

Key filing fact

Merck & Co., Inc. filed Form 3 for Personalis, Inc. (PSNL) on 23 Dec 2024.

Key facts

This page summarizes Merck & Co., Inc.'s Form 3 filing for Personalis, Inc. (PSNL).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 23 Dec 2024, 06:00.

Change

Previous filing in this sequence was filed on 11 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PSNL holding

Common Stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14,044,943
Date: 19 Dec 2024
Ownership: See footnotes
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On December 19, 2024, Merck Sharp & Dohme LLC ("MSD") entered into an Investment Agreement with Personalis, Inc. (the "Company"), pursuant to which MSD purchased from the Company 14,044,943 shares of the Company's common stock, par value $0.0001 per share, at a price per share of $3.56.

Footnote F2

MSD is a direct wholly-owned subsidiary of Merck & Co., Inc. ("Merck", and together with MSD, the "Reporting Persons").

Footnote F3

Each of the Reporting Persons declare that the filing of this Form 3 shall not be construed as an admission that the Reporting Persons are the beneficial owners of any securities reported in this Form 3.